For patients

How melanoma is diagnosed

A diagnosis moves through a set sequence: an exam, a biopsy, a pathology report, and then staging. Knowing the sequence makes the waiting easier to bear.

The skin exam

A dermatologist looks at the spot and at the rest of your skin, usually with a dermatoscope, a handheld magnifier with polarized light. The exam decides whether a biopsy is needed.

The biopsy

The doctor numbs the skin and removes the spot, ideally all of it, in a few minutes. No scan or blood test can replace this step.1

The pathology report

A pathologist, often a dermatopathologist, examines the tissue under a microscope and writes the diagnosis. For melanoma the report lists Breslow thickness, ulceration, mitotic rate, and margins.2

Staging

Thickness and ulceration set the tumor category. For melanomas thicker than about 1 millimeter, and for some thinner ones, doctors discuss a sentinel lymph node biopsy to check the nearest lymph node.3 Scans are reserved for higher stages or for symptoms.

The plan

Your team combines the findings into a stage from 0 to IV, and the stage guides treatment.

If a lymph node is positive

A positive sentinel node used to mean a second, larger operation to remove the remaining nodes. The MSLT-II trial followed 1,934 patients and found that careful observation with ultrasound gave the same melanoma-specific survival as immediate surgery, with far less lymphedema.4 Most patients now avoid the larger operation.

When a second opinion helps

Some pigmented lesions are hard to classify, even for experts. In a study of 187 pathologists reading 240 cases, agreement was high for clearly benign and clearly invasive lesions and much lower for the categories in between.5 Asking for a second dermatopathologist to review the slides is a reasonable request, and laboratories handle it routinely.

References

  1. National Cancer Institute. Melanoma treatment (PDQ), patient version. https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq
  2. Gershenwald JE, Scolyer RA, Hess KR, and colleagues. Melanoma staging: evidence-based changes in the AJCC eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians. 2017. https://doi.org/10.3322/caac.21409
  3. Wong SL, Faries MB, Kennedy EB, and colleagues. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: ASCO and SSO guideline update. Journal of Clinical Oncology. 2018. https://pubmed.ncbi.nlm.nih.gov/29232171/
  4. Faries MB, Thompson JF, Cochran AJ, and colleagues. Completion dissection or observation for sentinel-node metastasis in melanoma (MSLT-II). New England Journal of Medicine. 2017. https://pubmed.ncbi.nlm.nih.gov/28591523/
  5. Elmore JG, Barnhill RL, Elder DE, and colleagues. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations. BMJ. 2017. https://pubmed.ncbi.nlm.nih.gov/28659278/

Reviewed against these sources in September 2026. Figures change every year, and this page is updated when new estimates are released.

The information provided on this website is not intended to serve as a replacement for the advice, diagnosis, or treatment provided by a qualified medical professional. If you have any questions about a medical condition, you should never hesitate to consult with either your primary care physician or another qualified healthcare provider. You should never disregard the advice of a qualified medical professional or put off getting treatment because of something you have read on this website.
Ask a question